Prof. Dr. Jan Borén is a Professor and the Head of the Institute of Medicine, Sahlgrenska Academy, at the University of Gothenburg and a Physician at the Department of Clinical Chemistry of the Sahlgrenska University Hospital. He obtained his Medical Degree at the University of Gothenburg in 1988, where he also completed his Ph.D. in 1992. His main research interest is lipid metabolism, and he has focused on
understanding the consequences of and underlying mechanisms that lead to lipid accumulation in the liver, arterial wall, and heart, intending to translate this knowledge into effective treatment. His research program is translational and involves both in vitro and in vivo studies, including pathophysiological
studies and mouse models and kinetic studies in carefully phenotyped human volunteers. He is a member of the Royal Society of Arts and Sciences in Gothenburg and has been awarded numerous honors, including the Göran Gustafsson’s Prize in Medicine from the Royal Academy of Sciences, Dr. Eric K
Fernström Foundation’s Research Award, and the Irvine H. Page Atherosclerosis Research Award. He also serves as Vice-President of the European Atherosclerosis Society (EAS) and is an Editorial Board Member of Arteriosclerosis, Thrombosis, and Vascular Biology, Section Editor for BBA-Molecular and Cell Biology of Lipids, and Co-Editor of Atherosclerosis.
Research Keywords & Expertise
Lipids
Metabolism
lipoproteins
Atherosclerosis sectio...
Fingerprints
52%
Metabolism
39%
Lipids
35%
lipoproteins
Short Biography
Prof. Dr. Jan Borén is a Professor and the Head of the Institute of Medicine, Sahlgrenska Academy, at the University of Gothenburg and a Physician at the Department of Clinical Chemistry of the Sahlgrenska University Hospital. He obtained his Medical Degree at the University of Gothenburg in 1988, where he also completed his Ph.D. in 1992. His main research interest is lipid metabolism, and he has focused on
understanding the consequences of and underlying mechanisms that lead to lipid accumulation in the liver, arterial wall, and heart, intending to translate this knowledge into effective treatment. His research program is translational and involves both in vitro and in vivo studies, including pathophysiological
studies and mouse models and kinetic studies in carefully phenotyped human volunteers. He is a member of the Royal Society of Arts and Sciences in Gothenburg and has been awarded numerous honors, including the Göran Gustafsson’s Prize in Medicine from the Royal Academy of Sciences, Dr. Eric K
Fernström Foundation’s Research Award, and the Irvine H. Page Atherosclerosis Research Award. He also serves as Vice-President of the European Atherosclerosis Society (EAS) and is an Editorial Board Member of Arteriosclerosis, Thrombosis, and Vascular Biology, Section Editor for BBA-Molecular and Cell Biology of Lipids, and Co-Editor of Atherosclerosis.